USP14 Inhibition to Accelerate Proteasomal Degradation of Synaptic Substrates

Mechanistic description

Mechanism / pathway

USP14 (ubiquitin-specific peptidase 14)
→
proteomics

Evidence for (5)

USP14 inhibition enhances proteasome activity and reduces polyglutamine aggregation

PMID:21669869
USP14 knockdown improves synaptic function in aging Drosophila models

PMID:25327251
Proteasome subunits show reduced activity in AD hippocampus with accumulation of ubiquitinated proteins

PMID:29051325
IU1 derivatives penetrate blood-brain barrier and reduce protein aggregates in mouse models

PMID:31883851
DUBs are considered more druggable than transcription factors with defined active sites

PMID:21669869

Evidence against (6)

VLX1570 DUB inhibitor reached Phase 1/2 and was terminated due to toxicity (cardiac/vascular)

PMID:NCT02667873
USP14 knockout mice develop sensorineural defects indicating essential functions

PMID:20414257
IU1 inhibits otulin and CYLD at relevant concentrations - poor selectivity

PMID:30224379
b-AP15/PR-157 acts on proteasome 19S subunit PSMD4, not USP14

PMID:30224379
USP14 performs quality control editing of ubiquitin chains - complete inhibition eliminates checkpoint

PMID:21669869
Proteasome 'bounce-back' response triggers compensatory downregulation after pharmacologic activation

PMID:21813639

Evidence matrix

5 supporting 6 contradicting

47% posterior support

Supporting

USP14 inhibition enhances proteasome activity and reduces polyglutamine aggregation PMID:21669869
USP14 knockdown improves synaptic function in aging Drosophila models PMID:25327251
Proteasome subunits show reduced activity in AD hippocampus with accumulation of ubiquitinated proteins PMID:29051325
IU1 derivatives penetrate blood-brain barrier and reduce protein aggregates in mouse models PMID:31883851
DUBs are considered more druggable than transcription factors with defined active sites PMID:21669869

Contradicting

VLX1570 DUB inhibitor reached Phase 1/2 and was terminated due to toxicity (cardiac/vascular) PMID:NCT02667873
USP14 knockout mice develop sensorineural defects indicating essential functions PMID:20414257
IU1 inhibits otulin and CYLD at relevant concentrations - poor selectivity PMID:30224379
b-AP15/PR-157 acts on proteasome 19S subunit PSMD4, not USP14 PMID:30224379
USP14 performs quality control editing of ubiquitin chains - complete inhibition eliminates checkpoint PMID:21669869
Proteasome 'bounce-back' response triggers compensatory downregulation after pharmacologic activation PMID:21813639

Bayesian persona consensus

47% posterior support

1 signal · 0 for / 1 against · agreement 0%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). USP14 Inhibition to Accelerate Proteasomal Degradation of Synaptic Substrates. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-92a69aa3

BibTeX

@misc{scidex_hypothesis_h92a69aa,
  title        = {USP14 Inhibition to Accelerate Proteasomal Degradation of Synaptic Substrates},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-92a69aa3},
  note         = {SciDEX artifact hypothesis:h-92a69aa3}
}